Literature DB >> 26295731

Lenalidomide monotherapy leads to a complete remission in refractory B-cell post-transplant lymphoproliferative disorder.

Heinz Läubli1,2, Alexandar Tzankov3, Darius Juskevicius3, Lukas Degen4, Christoph Rochlitz1, Frank Stenner-Liewen1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26295731     DOI： 10.3109/10428194.2015.1083563

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  2 in total

1.  Distinct genetic evolution patterns of relapsing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysis.

Authors:  D Juskevicius; T Lorber; J Gsponer; V Perrina; C Ruiz; F Stenner-Liewen; S Dirnhofer; A Tzankov
Journal:  Leukemia       Date:  2016-05-20       Impact factor: 11.528

Review 2.  Epstein-Barr virus-related post-transplant lymphoproliferative disease (EBV-PTLD) in the setting of allogeneic stem cell transplantation: a comprehensive review from pathogenesis to forthcoming treatment modalities.

Authors:  Rama Al Hamed; Abdul Hamid Bazarbachi; Mohamad Mohty
Journal:  Bone Marrow Transplant       Date:  2019-05-14       Impact factor: 5.483
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.